Sunday, September 15, 2013 3:24:14 PM
Polly, what about forward-looking posts like these that got just contemptuous replies here:
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=52974645
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=71990757
My point is it was a curious/abnormal series of events that led us to where we are now
And my point is that you are chasing gold at the end of the rainbow - of a generics company. And because its the generics business, every time it gets an approval, that means the door is open to OTHER approvals of the same brand, without warning not notice, regardless of whether they occur on the same day, the same year, or next year, etc. By now you understand what competition means in generics pricing, and that in reality the much sought-after "duopoly" amounts to an investment on the edge of a cliff.
Cannabix Technologies Announces First Delivery of Marijuana Breath Test (MBT) to a Major Construction Client • BLOZF • Mar 19, 2026 12:45 PM
ECGI Building in Crypto's Top-Performing Sector as Tokenized Real-World Assets Surge Past $26 Billion • ECGI • Mar 19, 2026 8:30 AM
Advances in Domestic Heavy Rare Earth Minerals Production Essential for North American Defense Stockpiles • ALOY • Mar 18, 2026 9:00 AM
ECGI Advances $10M Mortgage Tokenization Pilot as SEC Interpretation Adds Clarity • ECGI • Mar 18, 2026 8:45 AM
ECGI Advances Mortgage Tokenization Pilot as Institutional Market Rails Continue to Develop • ECGI • Mar 17, 2026 8:30 AM
Record Gold Prices Reshape Economics of New Mine Development • SNWGF • Mar 16, 2026 10:46 AM
